ConductScience.org, home

Cell line · CVCL_1045

22Rv1

Cancer cell line, Homo sapiens. Prostate carcinoma. 217 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. 22Rv1. Cell lines, record CVCL_1045. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1045

On this page

Cell line

As Cellosaurus gives it.

Name
22Rv1
Accession
CVCL_1045
RRID
RRID:CVCL_1045
Synonyms
22RV1, 22Rv-1, 22rV1, CWR-22rv1, CWR22-Rv1, CWR22R-V1, CWR22-R1, CWR22Rv1, CWR22R
Species
Homo sapiens (Human)
Sex
Male
Age at sampling
Adult
Category
Cancer cell line
Diseases
Prostate carcinoma (NCIt C4863)
Derived from
Prostate (in situ)
Parent
CWR22 (CVCL_3967)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers217

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

PaperJournalYearHow we knowRetractedSource
In vivo validation of intramolecular bivalent glues targeting PSMA reveals potent and tissue-selective BRD4 degradation in prostate cancer.Acta Pharm Sin B2026Its Methods give the RRID and name the linePubMed
Obesity-Induced PLPE-PTK6-FASN Feedback Loop Drives Enzalutamide Resistance by Exacerbating Lipid Metabolic Dysregulation in Castration-Resistant Prostate Cancer.Research (Wash D C)2026Its Methods give the RRID and name the linePubMed
Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer.Cancer Res2026Its Methods give the RRID and name the linePubMed
Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2.Mol Oncol2026Its Methods give the RRID and name the linePubMed
SLPI is associated with AR-regulated epithelial adaptation and enzalutamide sensitivity in castration-resistant prostate cancer.Front Pharmacol2026Its Methods give the RRID and name the linePubMed
Vitronectin Enrichment in Prostate Cancer Liver Metastases Promotes Adhesion and Survival.Cancer Res Commun2026Its Methods give the RRID and name the linePubMed
Multi-omics dissection of FOXA1 reveals cancer-type-specific transcriptional networks and functional risk variants.iScience2026Its Methods give the RRID and name the linePubMed
Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis.Br J Cancer2026Its Methods give the RRID and name the linePubMed
Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status.Br J Cancer2026Its Methods give the RRID and name the linePubMed
Lactate-induced H3K4me3 histone mark promotes PLOD1-driven prostate cancer invasion.Cell Death Dis2026Its Methods give the RRID and name the linePubMed

1 to 10 of 217

See all 217 papers

Relatives24

RelationCell lineAccessionProblemSource
ParentCWR22CVCL_3967Cell lines
Derived from it22RV1-EGFPCVCL_C8WACell lines
Derived from it22RV1-LucCVCL_C8UTCell lines
Derived from it22RV1rYM155_300nMCVCL_RS39Cell lines
Derived from it22Rv1 CHD7 KO clone 2A2CVCL_E8SCCell lines
Derived from it22Rv1 RCVCL_4Y35Cell lines
Derived from it22Rv1-CHD7 KO clone 1C2CVCL_E8SDCell lines
Derived from it22Rv1-CabR1CVCL_A6PGCell lines
Derived from it22Rv1-CabR2CVCL_A6PHCell lines
Derived from it22Rv1-SLCVCL_WZ28Cell lines

Cell banks9

Cell bankCatalog numberStatusSource
ATCCCRL-2505ATCC
BCRC60545BCRC
CCTCCGDC0288Cellosaurus
CLS305037CLS
DSMZACC-438DSMZ
ECACC05092802ECACC
EDITGENEEDC00358EDITGENE
KCBKCB 200731YJCellosaurus
UbigeneYC-C012Ubigene

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1045

GET https://conductscience.org/api/cell-lines/v1/CVCL_1045/papers?page=2